CANDEL THERAPEUTICS, INC. Interest Income (Expense), Net
CANDEL THERAPEUTICS, INC. (CADL) reported Interest Income (Expense), Net of $102.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2023-05-11
- CANDEL THERAPEUTICS, INC. interest income (expense), net for the quarter ending 2023-03-31 was $102.00K.
- CANDEL THERAPEUTICS, INC. interest income (expense), net for the quarter ending 2022-03-31 was -$175.00K.
| Period end | Interest Income (Expense), Net 3 month |
|---|---|
| 2023-03-31 | $102.00K 10-Q · filed 2023-05-11 |
| 2022-03-31 | -$175.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |